首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

全球 MRI 造影劑市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1346848

全球 MRI 造影劑市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global MRI Contrast Media Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球 MRI 造影劑市場需求預計將從 2022 年的 29.8 億美元達到 2030 年近 55.8 億美元的市場規模，2023-2030 年研究期間年複合成長率為 8.15%。

MRI（磁共振成像）造影劑，也稱為造影劑，是 MRI 過程中使用的物質，用於增強體內特定組織和結構的可見度。將造影劑引入體內，在不同組織之間產生更強的對比度，有助於某些區域的可視化並提高 MRI 的診斷準確性。

市場動態：

由於對精確診斷成像的需求、技術進步以及需要成像的醫療狀況的日益普遍等因素，MRI 造影劑市場正在擴大。造影劑可增強 MRI 掃描期間特定組織的可見度，從而實現準確的診斷並改進治療計劃。對非侵入性成像程序不斷成長的需求以及將對比增強 MRI 涵蓋臨床指南推動了市場成長。技術創新有助於提高圖像品質、安全性和患者治療效果。人口老齡化和慢性病發病率的上升需要頻繁的成像，進一步刺激了對造影劑的需求。正在進行的研究重點是開發更安全、更有效的藥物，以解決安全問題並改善患者的治療結果。隨著醫療保健提供者優先考慮準確的成像和以患者為中心的護理，MRI 掃描中造影劑的使用有望擴大，特別是在醫療保健基礎設施不斷發展的新興市場。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球核磁共振造影劑市場的各個細分市場進行了包容性評估。核磁共振造影劑行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 MRI 造影劑市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 MRI 造影劑市場的主要參與者包括 GE Healthcare、Bayer AG、Guerbet GmbH、Bracco Imaging Spa、Vitalquan, LLC、Miltenyi Biotec BV & Co. Kg。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
行業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 按類型分類的市場吸引力分析
- 市場吸引力分析：按應用分類
- 按最終用途分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷管道發展趨勢

第 5 章：全球 MRI 造影劑市場分析：按產品分類

按產品概述
歷史和預測數據
按產品分析
順磁劑
超順磁劑

第 6 章：全球 MRI 造影劑市場分析：按類型

按類型概述
歷史和預測數據
按類型分析
臨床
臨床前

第 7 章：全球 MRI 造影劑市場分析：按應用分類

概述：按應用
歷史和預測數據
分析：按應用
胃腸道
靜脈
肝膽
神經影像
其他

第 8 章：全球 MRI 造影劑市場分析：按最終用途分類

按最終用途分類的概述
歷史和預測數據
按最終用途分析
醫院
影像中心

第 9 章：全球 MRI 造影劑市場分析：按地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史和預測數據銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史和預測數據銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：MRI 造影劑代理商公司的競爭格局

Mri 對比介質代理市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

公司股份分析
市場集中度
GE Healthcare

公司簡介
公司收入
產品
最近的發展

Bayer AG

公司簡介
公司收入
產品
最近的發展

Guerbet GmbH

公司簡介
公司收入
產品
最近的發展

Bracco Imaging Spa

公司簡介
公司收入
產品
最近的發展

Vitalquan LLC

公司簡介
公司收入
產品
最近的發展

Miltenyi Biotec BV & Co. Kg

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112112012

The global demand for MRI Contrast Media Agents Market is presumed to reach the market size of nearly USD 5.58 BN by 2030 from USD 2.98 BN in 2022 with a CAGR of 8.15% under the study period 2023 - 2030.

MRI (Magnetic Resonance Imaging) contrast media agents, also known as contrast agents, are substances used during MRI procedures to enhance the visibility of specific tissues and structures within the body. Contrast media agents are introduced into the body to create a stronger contrast between different tissues, aiding in the visualization of certain areas and improving the diagnostic accuracy of the MRI.

MARKET DYNAMICS:

The MRI Contrast Media Agents market is expanding due to factors such as the demand for precise diagnostic imaging, technological advancements, and the increasing prevalence of medical conditions requiring imaging. Contrast media agents enhance the visibility of specific tissues during MRI scans, leading to accurate diagnoses and improved treatment planning. The rising demand for non-invasive imaging procedures and the incorporation of contrast-enhanced MRI in clinical guidelines drive market growth. Technological innovations contribute to improved image quality, safety, and patient outcomes. The ageing population and the higher incidence of chronic diseases necessitate frequent imaging, further fueling the demand for contrast media agents. Ongoing research focuses on developing safer and more efficient agents to address safety concerns and improve patient outcomes. As healthcare providers prioritize accurate imaging and patient-centric care, the utilization of contrast media agents in MRI scans is poised to expand, particularly in emerging markets with growing healthcare infrastructure.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mri contrast media agents. The growth and trends of mri contrast media agents industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the mri contrast media agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Paramagnetic Agents
Superparamagnetic Agents

By Type

Clinical
Preclinical

By Application

Gastrointestinal
Intravenous
Hepatobiliary
Neurological Imaging
Others

By End-Use

Hospitals
Imaging Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the MRI Contrast Media Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the MRI Contrast Media Agents market include GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging Spa, Vitalquan, LLC, Miltenyi Biotec B.V. & Co. Kg. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MRI CONTRAST MEDIA AGENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Paramagnetic Agents Historic and Forecast Sales by Regions
5.5 Superparamagnetic Agents Historic and Forecast Sales by Regions

6 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Clinical Historic and Forecast Sales by Regions
6.5 Preclinical Historic and Forecast Sales by Regions

7 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Gastrointestinal Historic and Forecast Sales by Regions
7.5 Intravenous Historic and Forecast Sales by Regions
7.6 Hepatobiliary Historic and Forecast Sales by Regions
7.7 Neurological Imaging Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY END-USE

8.1 Overview by End-use
8.2 Historical and Forecast Data
8.3 Analysis by End-use
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Imaging Centers Historic and Forecast Sales by Regions

9 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE MRI CONTRAST MEDIA AGENTS COMPANIES

10.1. Mri Contrast Media Agents Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF MRI CONTRAST MEDIA AGENTS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. GE Healthcare
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Bayer AG
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Guerbet GmbH
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Bracco Imaging Spa
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Vitalquan LLC
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Miltenyi Biotec B.V. & Co. Kg
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments